Identification of thymidylate synthase as a potential therapeutic target for lung cancer

被引：0
|
作者：
K Takezawa
I Okamoto
S Tsukioka
J Uchida
M Kiniwa
M Fukuoka
K Nakagawa
机构：
[1] Kinki University School of Medicine,Department of Medical Oncology
[2] Tokushima Research Center,Department of Medical Oncology
[3] Taiho Pharmaceutical Co. Ltd,undefined
[4] Kinki University School of Medicine,undefined
[5] Sakai Hospital,undefined
[6] 2-7-1 Harayamadai,undefined
[7] Minami-ku Sakai,undefined
[8] Osaka 590-0132,undefined
[9] Japan,undefined
来源：
British Journal of Cancer | 2010年 / 103卷
关键词：
thymidylate synthase; lung cancer; RNA interference; apoptosis; cell cycle;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：354 / 361
页数：7
相关论文
共 50 条
  • [41] Identification of phosphoenolpyruvate carboxykinase 1 as a potential therapeutic target for pancreatic cancer
    Zhu, Xiao-ren
    Peng, Shi-qing
    Wang, Le
    Chen, Xiao-yu
    Feng, Chun-xia
    Liu, Yuan-yuan
    Chen, Min-bin
    CELL DEATH & DISEASE, 2021, 12 (10)
  • [42] Identification of the mitochondrial protein POLRMT as a potential therapeutic target of prostate cancer
    Li, Xiaojun
    Yao, Linya
    Wang, Tao
    Gu, Xiaolei
    Wu, Yufan
    Jiang, Ting
    CELL DEATH & DISEASE, 2023, 14 (10)
  • [43] Identification of Anaplastic Lymphoma Kinase as a Potential Therapeutic Target in Ovarian Cancer
    Ren, Hong
    Tan, Zhi-Ping
    Zhu, Xin
    Crosby, Katherine
    Haack, Herbert
    Ren, Jian-Min
    Beausoleil, Sean
    Moritz, Albrecht
    Innocenti, Gregory
    Rush, John
    Zhang, Yi
    Zhou, Xin-Min
    Gu, Ting-Lei
    Yang, Yi-Feng
    Comb, Michael J.
    CANCER RESEARCH, 2012, 72 (13) : 3312 - 3323
  • [44] Thymidylate synthase inhibitors for non-small cell lung cancer
    Galvani, Elena
    Peters, Godefridus J.
    Giovannetti, Elisa
    EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2011, 20 (10) : 1343 - 1356
  • [45] Inhibition of nitric oxide synthase as a potential therapeutic target
    Hobbs, AJ
    Higgs, A
    Moncada, S
    ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY, 1999, 39 : 191 - 220
  • [46] THYMIDYLATE SYNTHASE - A TARGET FOR ANTICANCER DRUG DESIGN
    HARRAP, KR
    JACKMAN, AL
    NEWELL, DR
    TAYLOR, GA
    HUGHES, LR
    CALVERT, AH
    ADVANCES IN ENZYME REGULATION, 1989, 29 : 161 - 179
  • [47] Thymidylate synthase: A target for combination therapy and determinant of chemotherapeutic response in colorectal cancer
    Van Triest, B
    Peters, GJ
    ONCOLOGY, 1999, 57 (03) : 179 - 194
  • [48] THYMIDYLATE SYNTHASE - A TARGET FOR ANTICANCER DRUG DESIGN
    HARRAP, KR
    JACKMAN, AL
    NEWELL, DR
    TAYLOR, GA
    HUGHES, LR
    CALVERT, AH
    ADVANCES IN ENZYME REGULATION, VOL 29, 1989, 29 : 161 - 179
  • [49] Determinants of the therapeutic efficacy of thymidylate synthase inhibitors
    Peters, GJ
    Kuiper, CM
    van Triest, B
    Backus, H
    van der Wilt, CL
    van Laar, JAM
    Jansen, G
    van Groeningen, CJ
    Pinedo, HM
    PURINE AND PYRIMIDINE METABOLISM IN MAN IX, 1998, 431 : 699 - 704
  • [50] Identification of a novel therapeutic target in lung adenocarcinoma
    Enfield, Katey S. S.
    Marshall, Erin A.
    Anderson, Christine
    Ng, Kevin W.
    Rahmati, Sara
    Xu, Zhaolin
    MacAulay, Calum E.
    Lam, Stephen
    Lockwood, William W.
    Chari, Raj
    Karsan, Aly
    Jurisica, Igor
    Lam, Wan L.
    CLINICAL CANCER RESEARCH, 2018, 24 (17)
12345